Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

U.S. government to ship 18.5 million doses of COVID vaccine this week, White House says

Published 03/09/2021, 03:54 PM
Updated 03/09/2021, 04:00 PM
© Reuters. Outbreak of the coronavirus disease (COVID-19) in Ronda
JNJ
-
MRNA
-

(Reuters) - The White House said on Tuesday that the government will distribute around 18.5 million doses of COVID-19 vaccines this week, fewer than last week because no new doses of Johnson & Johnson (NYSE:JNJ)'s vaccine are ready to be sent out.

White House press secretary Jen Psaki said at a news briefing that the U.S. government plans to distribute 15.8 million doses of the Pfizer/BioNTech and Moderna (NASDAQ:MRNA) vaccine to states, tribes and territories, along with 2.7 million doses going to pharmacies.

Last week, the U.S. government distributed over 21 million doses of all three vaccines. That included over 3.5 million doses of the newly authorized J&J vaccine.

J&J's manufacturing has been slower than expected, and the company was not expected to be able to deliver any doses of its vaccine this week. It is expected to resume shipments of the vaccine later in March.

© Reuters. Outbreak of the coronavirus disease (COVID-19) in Ronda

As of Tuesday morning, more than 123 million doses of the vaccines had been distributed in the United States and 93.7 million shots had been administered, according to data from the U.S. Centers for Disease Control and Prevention.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.